Sunday, February 10, 2013

FDA Focuses on Early-Stage Alzheimer's, Seeks Feedback

The FDA has a new Alzheimer's-fighting plan. They are seeking public comments for the next 60 days. They plan to identify and study patients with very early Alzheimer’s disease, so they can be treated before there is too much irreversible damage to the brain. Learn why. Offer your input.

Read more »